Clinical Study
Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes
Table 2
Intraoperative and postoperative results with high intensity focused ultrasound.
| Anesthesia used | | Spinal anesthesia | 109 | General anesthesia | 1 | Ablatherm device | | EDAP-Technomed Ablatherm | 59 | Ablatherm Integrated Imaging | 51 | Preoperative complications | 0 | Concomitant TURP, (%) | | Yes | 79 (71.8) | No | 31 (28.2) | Hospital stays in days, median (range) | 4 (2–7) | Catheterization time in days, median (range) | 6 (2–30) | Postoperative prostatic volume in mL, median (range) | 14 (6–22) | Time to PSA nadir in weeks, mean (range) | 16.3 ± 8.2 (4–46) | PSA nadir in ng/mL, mean (range) | 0.55 ± 1.34 (0–8.29) | PSA < 0.5 ng/mL, (%) | 72 (65.5) | PSA 0.5–1 ng/mL, (%) | 17 (15.5) | PSA 1–4 ng/mL, (%) | 19 (17.2) | PSA > 4 ng/mL, (%) | 2 (1.8) | Follow-up in months, median (range) | 94 (13–139) | Lost to follow-up, (%) | 2 (1.8) |
|
|